Peptide for treatment of type 2 diabetes mellitus and its complications

The invention relates to biotechnology. The exenatide analogue with the formula H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-As-Leu-Ser-Lys-Gln-Glu-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro- Pro-Ser-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-OH is pres...

Full description

Saved in:
Bibliographic Details
Main Authors Vladimir Aleksandrovich KASHKIN, Mikhail Ivanovich TITOV, Ivan Ivanovich ELISEEV, Valery Gennadyevich MAKAROV, Elena Vasilyevna SHEKUNOVA, Marina Nikolaevna MAKAROVA
Format Patent
LanguageEnglish
Hebrew
Published 31.10.2021
Online AccessGet full text

Cover

More Information
Summary:The invention relates to biotechnology. The exenatide analogue with the formula H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-As-Leu-Ser-Lys-Gln-Glu-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro- Pro-Ser-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-OH is presented. The invention allows treating and taking preventive measures against diabetes mellitus as well as treating and taking preventive measures against type 2 diabetes mellitus complications, such as diabetic neuropathy, muscular dystrophy and endotheliopathy.
Bibliography:Application Number: IL20170250666